Long-term outcomes of moderately hypofractionated radiotherapy (67.5 Gy in 25 fractions) for prostate cancer confined to the pelvis: a single center retrospective analysis

BACKGROUND: There is an increasing application of moderately hypofractionated radiotherapy for prostate cancer. We presented our outcomes and treatment-related toxicities with moderately hypofractionated (67.5 Gy in 25 fractions) radiotherapy for a group of advanced prostate cancer patients from Chi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Lihong, Shou, Jianzhong, Wang, Shulian, Song, Yongwen, Fang, Hui, Lu, Ningning, Tang, Yuan, Chen, Bo, Qi, Shunan, Yang, Yong, Jing, Hao, Jin, Jing, Yu, Zihao, Li, Yexiong, Liu, Yueping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532562/
https://www.ncbi.nlm.nih.gov/pubmed/33008404
http://dx.doi.org/10.1186/s13014-020-01679-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532562/
https://www.ncbi.nlm.nih.gov/pubmed/33008404
http://dx.doi.org/10.1186/s13014-020-01679-0

Ejemplares similares